查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1456902

生物安全柜市场 - 2024年至2029年预测

Biological Safety Cabinet Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

2022年生物安全柜市场价值为138,221,000美元，预计复合年增长率为6.16%，到2029年市场规模将达到210,036,000美元。

生物安全柜是实验室和实验室使用的封闭柜，用于保护科学家和实验室人员免受污染材料处理过程中产生的生物危害和传染性物质的影响。该柜子配备了高效能颗粒过滤器 (HEPA)，可去除实验室空气中的病毒和细菌等传染源。由于其高安全性和高性能，在製药公司和研究机构的检测和诊断实验室具有很高的适用性。

由于对新药和有效疗法的需求不断增长，促进了製药业的成长，公司和政府组织的有利投资流入对生物安全柜市场的成长产生了积极影响。预计此类投资将增加药物测试应用中对生物安全柜的需求，并在预测期内提振柜市场。

市场趋势：

与传统 PSTN 服务相比，基于 IP 的服务越来越多地被采用，预计将在预测期内推动市场成长。云端运算使用量的增加、云端运算的快速采用以及企业整合通讯（UC）系统等因素预计将增加对生物安全柜的需求并推动整体市场成长。生物安全柜市场按公司规模、最终用户和地区细分。依公司规模，公司分为小型、中型和大型。依最终用户划分，可分为通讯/技术、医疗、零售、BFSI、政府等。

市场驱动因素：

  • 随着生命科学产业的良好投资流入和合作研究，生物安全柜的需求预计将激增。

高安全性生物安全柜主要用于生物实验室、研究、微生物学等人员及环境保护。製药公司正在投资新药和疫苗，并结成策略联盟，以解决患有重大疾病的人们未满足的需求。此外，2022 年 3 月，Blackstone Life Sciences 与赛诺菲建立策略伙伴关係，开发多发性骨髓瘤的治疗方法。预计此类设施和投资将刺激对生物安全柜的需求并在预测期内促进市场成长。

  • 对实验室安全的日益关注预计将对市场产生积极影响。

人们对实验室安全的日益关注对生物安全柜市场产生了重大影响，这推动了对这些基本安全壳系统的需求激增。随着实验室和研究机构优先考虑员工的健康并努力降低与处理生物材料相关的风险，平衡计分卡已成为安全通讯协定的重要组成部分。

严格遵守生物安全法规和指南显示了我们对实验室安全的重视。 BSC 专为满足这些严格标准而设计，提供受控环境，避免测试和加工过程中的污染和交叉污染。人们对可能的风险的认识不断提高，推动了最先进的生物安全柜技术的采用，并强调了对可靠的遏制解决方案的需求。

市场限制因素：

生物安全柜产业面临重大限制，可能会影响更广泛的接受度。一个主要挑战是购买、安装和认证生物安全柜的初始成本较高。所需的巨额支出可能令人望而却步，特别是对于预算有限的实验室和医疗机构。

总拥有成本进一步受到持续营运和维护成本的影响，例如频繁的认证和测试以确保符合安全法规。这种成本负担可能会影响资源有限的小型实验室和设施的决策流程。此外，身份验证和频繁维护的需要可能会导致停机，从而扰乱医院、研究设施等的持续运作。

  • 生物安全柜预计将成为成长最快的部分。

生物安全柜依类别分为一类、二类、三类。在生物安全柜市场的预测期内，II类生物安全柜预计将出现相对较高的成长率。 II级生物安全柜常用于基础研究和检测活动，并配有HEPA过滤器，因此柜体可以为产品、人员和环境提供更好的保护。随着更多用于生产和测试新药的研发设施的建立，对此类柜子的需求预计将会增加。此外，由于开发新药的各种研发投入，预计II级生物安全柜的需求也会增加。

亚太地区预计将成为主要区域市场

随着生物技术和生命科学研究的快速扩张，亚太生物安全柜市场受到多种因素的推动。随着该地区基因研究、药物开发和诊断设施的迅速增加，必须制定强有力的生物安全通讯协定。政府计划和大量研发支出进一步增强了对生物安全柜的需求，这符合该地区促进创新和科学发展的承诺。

由于人们越来越认识到处理生物材料的潜在危险以及遵守国际生物安全标准的需要，医疗机构和实验室正在将 BSC 纳入其安全措施。亚太地区充满活力的科学研究领域凸显了平衡计分卡作为确保安全职场的重要手段的重要性，从而导致许多领域生物安全通讯协定的扩展和改进。我是。

主要进展

  • 2023年6月，labculture(R) G4 II级A2型生物安全柜（LA2 G4）提高了生物安全柜技术创新与完善的标准。这款最先进的生物安全柜经过 NSF 认证的 BSC，为效率和安全性树立了新标准。
  • 2023 年 3 月，Labconco® 推出了更先进的微生物安全柜 ReVoTM，扩大了其广泛的生物安全产品范围。 ReVo 是精心设计的新型 II 级 A2 型生物安全解决方案。

目录

第一章 简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现
  • 分析师观点

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章生物安全柜市场：依类别

  • 介绍
  • Ⅰ类
    • 市场趋势和机会
    • 成长前景
  • 二级
    • 市场趋势和机会
    • 成长前景
  • 三级
    • 市场趋势和机会
    • 成长前景

第六章生物安全柜市场：依应用分类

  • 介绍
  • 致病性样本的处理
    • 市场趋势和机会
    • 成长前景
  • 研究开发应用
    • 市场趋势和机会
    • 成长前景

第七章生物安全柜市场：依最终用户分类

  • 介绍
  • 测试和诊断实验室
    • 市场趋势和机会
    • 成长前景
  • 研究机构
    • 市场趋势和机会
    • 成长前景

第八章生物安全柜市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 其他的
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 台湾
    • 泰国
    • 印尼
    • 其他的

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十章 公司简介

  • Esco Micro Pte. Ltd
  • Kewaunee International Group
  • Thermo Fisher Scientific
  • Baker
  • Labconco
  • Germfree Laboratories Inc.（EW Healthcare Partners）
  • Nuarie（Genuit）
  • Euroclone SpA
  • Air Science
简介目录
Product Code: KSI061611765

The biological safety cabinet market is evaluated at US$138.221 million for the year 2022 and is projected to grow at a CAGR of 6.16% to reach a market size of US$210.036 million by the year 2029.

A biological safety cabinet is an enclosed cabinet used in laboratories and research centers to protect scientists and laboratory personnel from any biohazard or infectious agents that occur during the processing of contaminated materials. The cabinet is equipped with a highly efficient particle-arresting filter (HEPA) which removes infection agents such as viruses & bacteria from the air in the laboratory. Owing to its high safety and performance features, the biological safety cabinet holds high applicability in testing & diagnostic laboratories of pharmaceutical companies and research institutes.

The bolstering growth in the pharmaceutical sector, owing to the growing demand for new and effective medical drugs for diseases, and favorable investment inflows both by companies and government organizations have positively impacted the market growth of the biological safety cabinet. Such investments are predicted to increase the demand for biological safety cabinets during the drug testing application, thereby boosting the market for the cabinets during the forecast period.

MARKET TRENDS:

The rising adoption of IP-based services over traditional PSTN services is projected to boost the market growth during the forecast period. Factors such as increasing usage of cloud computing, rapid adoption of cloud, and unified communication systems by enterprises are expected to increase the demand for Biological safety cabinets, thus boosting the overall market growth. The Biological safety cabinet market has been segmented based on enterprise size, end-user, and geography. Based on enterprise size, the market has been segmented into small, medium, and large. By end-user, the market has been segmented into communication and technology, healthcare, retail, BFSI, government, and others.

MARKET DRIVERS:

  • Favorable investment inflows and collaborations in the life sciences industry are predicted to create a surge in the demand for biological safety cabinets.

Biological safety cabinet owing to their safety features is majorly used in biological laboratories, research, and microbiology for personnel as well as environmental protection. Various pharmaceutical companies are undergoing strategic collaborations as well as investments in new drugs and vaccine development that could cater to the unmet needs of people suffering from major diseases. Furthermore, in March 2022, Blackstone Life Sciences entered into a strategic collaboration with Sanofi, for the development of the treatment for multiple myeloma. Such establishment and investments are anticipated to stimulate the demand for biological safety cabinets, thereby boosting its market growth during the forecast period.

  • A rising focus on laboratory safety is predicted to positively influence the market.

The biological safety cabinets (BSCs) market is significantly impacted by the growing emphasis on laboratory safety, which fuels a spike in demand for these essential containment systems. BSCs are essential parts of safety protocols as labs and research facilities put workers' health first and work to reduce the hazards involved in handling biological materials.

The strict observance of the rules and guidelines controlling biosafety is indicative of the emphasis on laboratory safety. BSCs offer a controlled environment that avoids contamination and cross-contamination during tests and processes since they are particularly made to comply with these strict criteria. The adoption of cutting-edge BSC technologies is fueled by the increased awareness of possible risks, which highlights the necessity for dependable containment solutions.

MARKET RESTRAINTS:

There are significant limitations faced by the biological safety cabinet (BSC) industry that may affect its broader acceptance. The major challenge is the initial high expense of buying, installing, and certifying BSCs. The substantial monetary outlay that is necessary might be prohibitive for labs and medical facilities, especially those with tight budgets.

The total cost of ownership is further impacted by continuing operating and maintenance costs, such as frequent certification and testing to guarantee adherence to safety regulations. The decision-making process of smaller laboratories or institutions with limited resources may be impacted by this cost burden. Furthermore, the requirement for certification and frequent maintenance might cause downtime, which would disrupt the ongoing operation in settings like hospitals and research facilities.

  • The biological safety cabinet is anticipated to be the fastest-growing segment.

Based on class type, the biological safety cabinet is segmented into class I, class II, and class III. The class II type biological safety cabinet is expected to grow at a relatively higher rate during the forecast period of the biological safety cabinet market. Class II biological safety cabinet has high usage in basic research and testing activities, and as it is equipped with a HEPA filter, the cabinet provides better protection to products, personnel, and the environment. With the growing establishment of R&D facilities for new drug production and testing, the demand for such cabinets is also expected to increase. Furthermore, owing to various investments in R&D for new drug development, the demand for class II biological safety cabinets is also projected to increase.

Asia Pacific is anticipated to be the major regional market.

The Asia Pacific biological safety cabinet (BSC) market is driven by various factors that coincide with the rapidly expanding fields of biotechnology and life sciences research. Strong biosafety protocols must be put in place since the number of facilities conducting genetic research, medication development, and diagnostics is rapidly growing in the area. The need for BSCs is further fueled by government programs and significant expenditures in research and development, which are in line with the region's commitment to promoting innovation and scientific developments.

Healthcare institutions and laboratories are incorporating BSCs into their safety measures because of the growing awareness of the possible hazards involved in handling biological materials and the requirement to adhere to international biosafety standards. The dynamic field of scientific research in the Asia Pacific area highlights the importance of BSCs as essential instruments for guaranteeing a safe workplace, thus fostering the expansion and improvement of biosafety protocols in many sectors.

Key Developments:

  • In June 2023, the labculture(R) G4 Class II Type A2 Biological Safety Cabinet (LA2 G4) raised the bar for innovation and perfection in biosafety cabinet technology. This state-of-the-art biosafety cabinet, an NSF-certified BSC, established a new benchmark for efficiency and safety. It is made to guarantee the protection of both users and products while offering an exceptional degree of containment.
  • In March 2023, with the advent of the ReVoTM, an additional cutting-edge microbiological safety cabinet, Labconco(R) expanded its wide range of biosafety products. ReVo is a new Class II, Type A2 biosafety solution that has been carefully designed.

Segmentation:

By Class Type

  • Class I
  • Class II
  • Class III

By Application

  • Pathogenic Samples Handling
  • Research & Development Applications

By End-User

  • Testing & Diagnostic Laboratories
  • Research Institutes

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key Benefits to the stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. BIOLOGICAL SAFETY CABINET MARKET, BY CLASS TYPE

  • 5.1. Introduction
  • 5.2. Class I
    • 5.2.1. Market Trends and Opportunities
    • 5.2.2. Growth Prospects
  • 5.3. Class II
    • 5.3.1. Market Trends and Opportunities
    • 5.3.2. Growth Prospects
  • 5.4. Class III
    • 5.4.1. Market Trends and Opportunities
    • 5.4.2. Growth Prospects

6. BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION

  • 6.1. Introduction
  • 6.2. Pathogenic Samples Handling
    • 6.2.1. Market Trends and Opportunities
    • 6.2.2. Growth Prospects
  • 6.3. Research & Development Applications
    • 6.3.1. Market Trends and Opportunities
    • 6.3.2. Growth Prospects

7. BIOLOGICAL SAFETY CABINET MARKET, BY END-USER

  • 7.1. Introduction
  • 7.2. Testing & Diagnostic Laboratories
    • 7.2.1. Market Trends and Opportunities
    • 7.2.2. Growth Prospects
  • 7.3. Research Institutes
    • 7.3.1. Market Trends and Opportunities
    • 7.3.2. Growth Prospects

8. BIOLOGICAL SAFETY CABINET MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
      • 8.2.1.1. Market Trends and Opportunities
      • 8.2.1.2. Growth Prospects
    • 8.2.2. Canada
      • 8.2.2.1. Market Trends and Opportunities
      • 8.2.2.2. Growth Prospects
    • 8.2.3. Mexico
      • 8.2.3.1. Market Trends and Opportunities
      • 8.2.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. Brazil
      • 8.3.1.1. Market Trends and Opportunities
      • 8.3.1.2. Growth Prospects
    • 8.3.2. Argentina
      • 8.3.2.1. Market Trends and Opportunities
      • 8.3.2.2. Growth Prospects
    • 8.3.3. Others
      • 8.3.3.1. Market Trends and Opportunities
      • 8.3.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. United Kingdom
      • 8.4.1.1. Market Trends and Opportunities
      • 8.4.1.2. Growth Prospects
    • 8.4.2. Germany
      • 8.4.2.1. Market Trends and Opportunities
      • 8.4.2.2. Growth Prospects
    • 8.4.3. France
      • 8.4.3.1. Market Trends and Opportunities
      • 8.4.3.2. Growth Prospects
    • 8.4.4. Spain
      • 8.4.4.1. Market Trends and Opportunities
      • 8.4.4.2. Growth Prospects
    • 8.4.5. Others
      • 8.4.5.1. Market Trends and Opportunities
      • 8.4.5.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
      • 8.5.1.1. Market Trends and Opportunities
      • 8.5.1.2. Growth Prospects
    • 8.5.2. UAE
      • 8.5.2.1. Market Trends and Opportunities
      • 8.5.2.2. Growth Prospects
    • 8.5.3. Israel
      • 8.5.3.1. Market Trends and Opportunities
      • 8.5.3.2. Growth Prospects
    • 8.5.4. Others
      • 8.5.4.1. Market Trends and Opportunities
      • 8.5.4.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. China
      • 8.6.1.1. Market Trends and Opportunities
      • 8.6.1.2. Growth Prospects
    • 8.6.2. Japan
      • 8.6.2.1. Market Trends and Opportunities
      • 8.6.2.2. Growth Prospects
    • 8.6.3. India
      • 8.6.3.1. Market Trends and Opportunities
      • 8.6.3.2. Growth Prospects
    • 8.6.4. South Korea
      • 8.6.4.1. Market Trends and Opportunities
      • 8.6.4.2. Growth Prospects
    • 8.6.5. Taiwan
      • 8.6.5.1. Market Trends and Opportunities
      • 8.6.5.2. Growth Prospects
    • 8.6.6. Thailand
      • 8.6.6.1. Market Trends and Opportunities
      • 8.6.6.2. Growth Prospects
    • 8.6.7. Indonesia
      • 8.6.7.1. Market Trends and Opportunities
      • 8.6.7.2. Growth Prospects
    • 8.6.8. Others
      • 8.6.8.1. Market Trends and Opportunities
      • 8.6.8.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Esco Micro Pte. Ltd
  • 10.2. Kewaunee International Group
  • 10.3. Thermo Fisher Scientific
  • 10.4. Baker
  • 10.5. Labconco
  • 10.6. Germfree Laboratories Inc. (EW Healthcare Partners)
  • 10.7. Nuarie (Genuit)
  • 10.8. Euroclone S.p.A
  • 10.9. Air Science